| INTRODUCTION
Fibrous dysplasia belongs to the heterogeneous group of fibro-osseous lesions composed by developmental and neoplastic conditions. 1 The diagnosis of fibrous dysplasia represents a challenge in clinical practice, since it requires correlation of clinical, radiological, histopathological, and surgical findings. 2 Therefore, a search for complementary diagnostic tools is essential. Establishing the correct diagnosis is essential, since different fibro-osseous lesions need different treatment modalities. 3 The classification of fibro-osseous lesions by the World Health Organization (WHO) is constantly being updated, as new studies gradually clarify the biological basis of these lesions. The latest WHO classification of head and neck tumors, published in 2017, allocated fibrous dysplasia, cemento-osseous dysplasia, ossifying fibroma, familial gigantiform cementoma, and osteochondroma in the group of "Fibro-osseous and osteochondromatous lesions." Cemento-ossifying fibroma was relocated into benign mesenchymal odontogenic tumors category. 4 Fibrous dysplasia is a developmental lesion characterized by substitution of normal bone by poorly organized woven bone and fibrous tissue. Clinically, it causes bone expansion asymmetry, and it is usually first diagnosed in childhood and adolescence. 1 Its onset generally matches with the active skeletal growth and present a selflimiting course, tending to stabilize. 5 This behavior is underlined by the causative postzygotic somatic mutations of GNAS1. 6 The GNAS1 gene mutation in fibrous dysplasia is a potential diagnostic adjuvant, as it is not found in normal bone tissue neither in other fibro-osseous lesions, such as ossifying fibroma. [7] [8] [9] In this review, we describe the current clinical, radiological, histopathological, and molecular aspects of fibrous dysplasia, as well as providing an overview of treatment perspectives and prognosis.
| CLINICAL AND RADIOLOGICAL

FEATURES
Fibrous dysplasia may involve one or more bones and these presen-type, and it usually involves the femur and the bones of the craniofacial skeleton. 10 In the craniofacial region, the maxilla is the most frequently affected site in monostotic fibrous dysplasia. Adjacent bones are also usually affected, and therefore, the term craniofacial fibrous dysplasia is preferred. Asymmetry, displacement of one or more teeth and malocclusion are frequent clinical features. 11 The most typical presentation of monostotic fibrous dysplasia is a slowgrowing painless enlargement in the affected area, but it can occasionally show a rapid development. 12 According to a large epidemiological study, the female to male ratio is 1.4:1.
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Fibrous dysplasia is radiologically characterized by homogeneous diffuse radiopacity with a ground glass appearance in continuity with normal bone (Figure 1 ). Bone expansion and thin cortices can be seen with CT. 14 The radiographic appearance change with the time and the homogenous "ground grass" appearance seen in young patients becomes more sclerotic.
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Fibrous dysplasia can be accompanied by endocrinopathies.
Increased levels of serum alkaline phosphatase are observed in 40%
of cases of polyostotic fibrous dysplasia and, more rarely, in monostotic form. 5 Polyostotic fibrous dysplasia is highly associated with the McCune-Albright syndrome (OMIM #174800). 15 Brownish and irregular cutaneous macules, called "café-au-lait" patches, are present in 66% of the cases associated with this syndromic condition. Hyperfunctioning endocrinopathies, FGF23-mediated renal phosphate wasting, and Cushing syndrome are also features usually associated with the syndrome. 16 Fibrous dysplasia associated only with cutaneous manifestations, such as "café-au-lait" macules, characterize
Jaffe-Lichtenstein syndrome.
| HISTOPATHOLOGICAL ASPECTS
The microscopic diagnosis of fibro-osseous lesions can be difficult due to important overlapping histopathological features observed in ossifying fibroma, osseous dysplasia, and fibrous dysplasia. The osseous component of fibrous dysplasia usually appears as elongated trabeculae of woven or lamellar bone with irregular curves giving rise to the frequently described Chinese letters/characters pattern ( Figure 2 ). Oval calcified structures resembling cementum are not commonly found, as they occur in ossifying fibromas and cemento-osseous dysplasia. Moreover, fibrous dysplasia also exhibits osteocytes in their osseous lacunae, but the presence of osteoblasts surrounding the trabeculae is not usually observed. 20 The lack of osteoblasts was previously considered a useful diagnostic feature for fibrous dysplasia; however, ossifying fibromas may also be devoid of osteoblasts, while some authors have also described this osteoblastic rimming in some fibrous dysplasias. 19 Therefore, this feature does not seem to carry a strong diagnostic significance.
Interestingly, fibrous dysplasia does not present the eosinophilic osteoid-like material in the periphery of the trabeculae as frequently seen in ossifying fibromas and does not contain the so-called brush borders in the osseous component like in ossifying fibroma. More recently, the presence of peri-trabecular clefting was reported as a hallmark of fibrous dysplasia, and it could be valuable for distinguishing it from ossifying fibroma.
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F I G U R E 1 A representative example of fibrous dysplasia computerized tomographic scan. Coronal (A) and axial (B) images show an expansive maxillary lesion with poorly defined borders
The most useful microscopic feature to differentiate fibrous dysplasia from ossifying fibroma is the relationship between its margins and the adjacent normal bone. 20, 22 In fibrous dysplasia cases, it is possible to observe a very close association of the lesional woven or lamellar bone and the adjacent normal trabeculaes which seem to blend in some areas (Figure 2A ), whereas in ossifying fibroma it is possible to observe a clear separation of the lesion from the surrounding normal bone due to the presence of a thin fibrous connective tissue. In contrast to ossifying fibroma that can be enucleated as a single or few large surgical specimens, fibrous dysplasia is surgically removed by curettage as multiple pieces of hard tissue.
As described above, there are several microscopic parameters that can be associated with clinical and radiological features to differentiate fibrous dysplasia and ossifying fibroma. However, the distinction between fibrous dysplasia and osseous dysplasia can be even more challenging and depending on the maturation stage of the diseases, both may present the same histopathological appearance. 22 Correlation of the microscopic findings with the clinical and radiological presentation of the lesions is mandatory in the differential diagnosis.
| MOLECULAR PATHOGE NESIS
Postzygotic somatic mutations of GNAS1 cause fibrous dysplasia. 23 Missense mutations in codon 201 of GNAS1 were first identified in McCune-Albright syndrome. As fibrous dysplasia is an important component of this syndrome, these mutations were later demonstrated in monostotic and polyostotic sporadic lesions (Figure 3 ). [24] [25] [26] Replacement of arginine by histidine at codon 201 of GNAS1 exon 8
is the most frequent mutation, but substitution by cysteine in this same codon may occur in few cases. More rare mutations in codon 224 of exon 9 have also been described. These mutations result in longer activation of Gsα and stimulation of endocrine system. Intracellular levels of cyclic adenosine monophosphate (cAMP) in osteoprogenitor cells increase as a consequence of Gsα activation.
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GNAS1 mutations were not identified in cemento-osseous dysplasia, ossifying fibromas, and normal bone, representing a fibrous dysplasia exclusive mutation. 7 Therefore, this genetic alteration is useful to distinguish these conditions. 31 Excessively high signaling levels may inhibit osteoblast maturation. In addition, Gαs loss decreases Wnt/β-catenin signaling. 32 Studies using animal models showed that mutant Gαs up- Cemento-ossifying fibroma is a well-circumscribed benign neoplasm which affects mostly the mandible and exhibits slow expansive growing. While microscopic examination reveals a fusion of fibrous dysplasia to the surrounding bone, cemento-ossifying fibroma frequently exhibits a surrounding fibrous connective tissue. 37 Radiographically, these features are visualized as poorly discernible borders that tend to blend with the unaffected bone in fibrous F I G U R E 3 Fibrous dysplasias are caused by somatic mosaicism of GNAS1 mutation. The mutational event would result in mosaicism of GNAS1 mutated (red) and GNAS1 wild-type cells (yellow). The occurrence of postzygotic mutation early in development, within a small population of non-mutated cells, results in the phenotype of McCune-Albright syndrome with skin, endocrine manifestations, and polyostotic fibrous dysplasia (A). Later events during embryogenesis within a larger population of cells lead to involvement limited to a single bone (monostotic) fibrous dysplasia (B). Both examples represent the end spectrum of the phenotype caused by the mutation dysplasia, contrasting with sharply defined borders in cemento-ossifying fibroma.
Focal cemento-osseous dysplasia tends to locate in the periapical regions or diffusely in tooth-bearing regions of the jaw bones, and cortical expansion is not usually a feature. Radiographically it is usually well delimited, unlike fibrous dysplasia, and its radiographic features are virtually diagnostic; hence, these lesions are often not biopsied. 38 Desmoplastic ameloblastoma mainly affects the anterior region of the mandible and may resemble radiographically to a fibroosseous lesion due to its mixed radiopaque/radiolucent appearance with ill-defined margins. 39 However, with the histopathological examination both lesions are easily differentiated.
The radiographic ground glass appearance is also observed in osteitis fibrosa/renal osteodystrophy, a skeletal manifestation of chronic kidney disease/mineral and bone disorder. This condition usually presents diffuse involvement of maxilla and mandible. Patients also show altered serum levels of calcium, phosphate, and parathyroid hormone, and therefore, knowledge on the systemic health condition of patients is very important to differentiate both entities. 36 Aggressive progression of fibrous dysplasia is a rare event.
Locally aggressive fibrous dysplasias in extra-cranial sites may be associated with malignant transformation or secondary aneurysmal bone cyst formation. 40 Considering the craniofacial region, the aggressive progression occurs in up to 5% of cases. In the presence of extension beyond the bone compartment into the soft tissue, nuclear morphology is a helpful feature for differentiation from lowgrade osteosarcoma. The presence of GNAS mutations is specific for fibrous dysplasia, and assessing these genetic alterations is especially helpful in challenging cases. 9, 41 In contrast, low-grade central osteosarcoma is a likely diagnosis in the presence of CDK4 overexpression and MDM2 amplification.
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| TREATMEN T AND PROGNOSIS
For the treatment planning of a patient with fibrous dysplasia, the surgeon should take into consideration that the progression of the lesion stops with its maturation. In the majority of cases, the lesion progresses throughout adolescence and tends to stabilize after puberty, when surgical reduction is usually performed because of cosmetic and functional reasons. Although, for the most part, the growth of fibrous dysplasia stops after adolescence, in some cases the lesion progresses into adulthood, with possible recurrences even in later life. Since age alone is not a reliable parameter to establish the appropriate time for surgical intervention, other predictive markers of the potential growth of fibrous dysplasia are required. 5 One study suggested that the levels of alkaline phosphatase can be considered a prognostic marker since its levels abruptly increase before the recurrence of some cases of craniofacial fibrous dysplasias. 46 However, a different study detected similar pre-operative levels of alkaline phosphatase in patients with or without recurrence. 5 Despite being a controversial predictive marker, alkaline phosphatase positively correlates with disease extent, once patients with polyostotic fibrous dysplasia show significantly higher levels than the ones with the monostotic form. 5 Obtaining a perfect symmetry in contouring surgery for maxillary fibrous dysplasia is a challenge that involves the accurate determination of the extent of bone resection in comparison with the contralateral side. Three-dimensional printing technology on CT has been suggested to pre-operatively determine the amount of surgical resection required and to improve esthetic results. 47 Spontaneous malignant transformation of fibrous dysplasia is a rare event with frequencies reported to be as low as 0.93%. 48 In the case of malignant transformation, the malignancies include osteosarcomas, fibrosarcomas, or chondrosarcomas. 49 Previous radiotherapy has been reported as a risk factor for the onset of malignant transformation in craniofacial fibrous dysplasia, and hence, it is no longer recommended for the treatment of these lesions. However, current knowledge about the pathogenesis of malignant transformation is limited since this process can occur in the absence of identifiable causal factors. 48 
| CONCLUSIONS
Fibrous dysplasia diagnosis can be challenging, and it requires correlation of all clinicopathological features. So far, the identification of GNAS1 mutations is the most useful molecular tool to differentiate fibrous dysplasia from other fibro-osseous lesions. The treatment and prognosis of this developmental condition are conditioned by the stabilization of its growth, and the results are generally favorable. However, cases associated with syndromes may require different approaches.
